| Name | Title | Contact Details |
|---|
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Danaher is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers.
South Country Health Alliance is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Owatonna, MN. To find more information about South Country Health Alliance, please visit www.mnscha.org
Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.
Oxylent has taken the multivitamin category by storm with its award-winning 5-in-1 formula that delivers vitamins, minerals, antioxidants, amino acids and electrolytes in one refreshing drink. Without the use of sugar, gluten, artificial additives, preservatives, dairy, caffeine, binders, or anti-caking agents, Oxylent is known in the market for using only the highest quality ingredients. Oxylent is the only effervescent multivitamin to be awarded Albion’s Gold Medallion, recognizing excellence in mineral formulation. The product contains no sugar and is sweetened with all-natural stevia, a plant-based sweetener that provides the sweetness of sugar without the calories or increase in blood sugar levels. Plus, Oxylent is 100 percent free of gluten, dairy, soy, GMOs and caffeine.